Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Hand (New York, N.Y.)|November 22, 2014
Postapproval clinical experience in the treatment of Dupuytren's contracture with collagenase clostridium histolyticum (CCH): the first 1,000 daysScott M Schulze, James P Tursi
The Journal of Sexual Medicine|May 6, 2015
Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic ApproachMartin K Gelbard, Larisa Chagan, James P Tursi
Journal of Medical Economics|February 2, 2017
The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular eventsWenjie Zhang, Yi Han, John G Fort, et al.
Journal of the Endocrine Society|December 9, 2020
Testosterone Use in Adolescent Males: Current Practice and Unmet NeedsMaria Vogiatzi, James P Tursi, Jonathan S Jaffe, et al.
Andrology|September 12, 2021
Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men ageAlexander W Pastuszak, Marc Gittelman, James P Tursi, et al.
The Journal of Hand Surgery|March 26, 2017
Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticumBrian J Bear, Clayton A Peimer, F Thomas D Kaplan, et al.
BJU International|March 31, 2015
Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD)Culley C Carson, Hossein Sadeghi-Nejad, James P Tursi, et al.
BJU International|February 26, 2015
Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studiesLarry I Lipshultz, Irwin Goldstein, Allen D Seftel, et al.
The Journal of Hand Surgery|December 10, 2013
Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contracturesStephen Coleman, David Gilpin, F Thomas D Kaplan, et al.
Urology|July 23, 2015
Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 StudiesWayne J G Hellstrom, Robert A Feldman, Karin S Coyne, et al.
Pageof 2